Autocrine activation-induced cell death of T cells by human peripheral blood monocyte-derived CD4+ dendritic cells

Cellular Immunology

Volumn 199, Issue 2, 2000, Pages 115-125

  Sato, Katsuaki ^a   Nagayama, Hitomi ^a   Enomoto, Makoto ^a   Tadokoro, Kenji ^b   Juji, Takeo ^b   Takahashi, Tsuneo A ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b JAPANESE RED CROSS MEDICAL CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; APOPTOSIS; ARTICLE; AUTOCRINE EFFECT; CELL DEATH; CELL PROLIFERATION; CELL STIMULATION; DENDRITIC CELL; HOMEOSTASIS; HUMAN; HUMAN CELL; MONOCYTE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 0034143631     PISSN: 00088749     EISSN: None     Source Type: Journal    
DOI: 10.1006/cimm.1999.1608     Document Type: Article

References (36)

1. Steinman R. M. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9:1991;271-296.
2. Deeg H. J., Aprile J., Storb R., Graham T. C., Hackman R., Appelbaum F. R., Schuening F. Functional dendritic cells are required for transfusion-induced sensitization in canine marrow graft recipient. Blood. 71:1988;1138-1140.
3. Larsen C. P., Morris P. J., Austyn J. M. Migration of dendritic leukocytes from cardiac allograft into host spleens: A novel pathway for initiation of rejection. J. Exp. Med. 171:1990;307-314.
4. Cameron P. U., Freudenthal P. S., Barker J. M., Gezelter S., Inaba K., Steinman R. M. Dendritic cells exposed to human immunodeficiency virus type-1 transmit a vigorous cytopathic infection to CD4 T cells. Science. 257:1992;383-387.
5. Austyn J. M. Antigen uptake and presentation by dendritic leukocytes. Semin. Immunol. 4:1992;227-236.
6. Austyn J. M. New insights into the mobilization and phagocytic dendritic cells. J. Exp. Med. 183:1996;1287-1292.
7. Caux C., Dezutter-Dambuyant C., Schmitt D., Banchereau J. GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells. Nature. 360:1992;258-261.
8. Hart D. N. J. Dendritic cells: Unique leukocyte populations which control the primary immune response. Blood. 90:1996;3245-3287.
9. Sallusto F., Lanzavecchia A. Efficent presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α J. Exp. Med. 179:1994;1109-1118.
10. + dendritic cells. Proc. Natl. Acad. Sci. USA. 93:1996;2588-2592.
11. + bone marrow precursors cultured with c-kit ligand, granulocyte-macrophage colony-stimulating factor, and TNF-α J. Immunol. 154:1995;5851-5861.
12. + hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF + TNF-α J. Exp. Med. 184:1996;695-706.
13. Saunders D., Lucas K., Ismaili J., Wu L., Maraskovsky E., Dunn A., Shortman K. Dendritic cell development in culture from thymic precursor cells in the absence of granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 184:1997;2185-2196.
14. Calvo C. R., Amsen D., Kruisbeek A. M. Cytotoxic T lymphocyte antigen 4 (CTLA-4) interferes with extracellular signal-regulated kinase (ERK) and jun NH2-terminal kinase (JNK) activation, but does not effect phosphorylation of T cell receptor z and ZAP-70. J. Exp. Med. 186:1997;1645-1653.
15. Perez V. L., Parijs L. V., Biuchians A., Zheng X. X., Strom T. B., Abbas A. K. Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. Immunity. 6:1997;411-417.
16. Lee K.-M., Chuang E., Griffin M., Khattri R., Hong D. K., Zhang W., Straus D., Samelson L. E., Thompson C. B., Bluestone J. A. Molecular basis of T cell inactivation by CTLA-4. Science. 282:1998;2263-2266.
17. Brugnoni D., Ario P., Graf D., Marconi M., Lebowitz M., Plebani A., Giliani S., Malacarne F., Cattaneo R., Ugazio A. G., Albertini A., Kroczek R. A., Notarangelo L. D. Ineffective expression of CD40 ligand on cord blood T cells may contribute to poor immunoglobulin production in the newborn. Eur. J. Immunol. 24:1994;1919-1924.
18. Durandy A., Basile G. D. S., Lisowska-Grospierre B., Gauchat J.-F., Forveille M., Kroczek R. A., Bonnefoy J.-Y., Fischer A. Undetectable CD40 ligand expression on T cells and low B cell responses to CD40 binding agonists in human newborn. J. Immunol. 154:1995;1560-1568.
19. Wong B., Arron J., Choi Y. T cell receptor signals enhance susceptibility to Fas-mediated apoptosis. J. Exp. Med. 186:1997;1939-1944.
20. Suda T., Hashimoto H., Tanaka M., Ochi T., Nagata S. Membrane Fas ligand kills human peripheral blood T lymphocytes and soluble Fas ligand blocks the killing. J. Exp. Med. 186:1997;2045-2050.
21. Suss G., Shortman K. A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis. J. Exp. Med. 183:1996;1789-1796.
22. Sato K., Nagayama H., Tadokoro K., Juji T., Takahashi T. A. Interleukin-13 is involved in functional maturation of human peripheral blood monocyte-derived dendritic cells. Exp. Hematol. 27:1999;326-336.
23. Sato K., Kawasaki H., Nagayama H., Serizawa R., Ikeda J., Morimoto C., Yasunaga Y., Yamaji N., Tadokoro K., Juji T., Takahashi T. A. CC chemokine receptors, CCR-1 and CCR-3, are potentially involved in antigen-presenting cell function of human peripheral blood monocyte-derived dendritic cells. Blood. 93:1999;34-42.
24. mapk are involved in IL-10-mediated selective repression of TNF-α-induced activation and maturation of human peripheral blood monocyte-derived dendritic cells. J. Immunol. 162:1999;3865-3872.
25. Sato K., Nagayama H., Tadokoro K., Juji T., Takahashi T. A. Aberrant CD3- and CD28-mediated signaling events in cord blood T cells are associated with dysfuctional regulation of Fas ligant-mediated cytotoxicity. J. Immunol. 162:1999;4464-4471.
26. + T cells resulting in a failure to lyse tumor cells. Blood. 93:1999;1634-1642.
27. + T cells in mice tolerant to Staphylococcus enterotoxin B. Nature. 349:1991;245-248.
28. + T cells. J. Immunol. 149:1992;3482-3488.
29. Chalmers I. M. H., Janossy G., Contreras M., Navarrete C. Intracellular cytokine profile of cord and adult blood lymphocytes. Blood. 92:1998;11-18.
30. Berthou C., Maida-Legros S., Soulie A., Wargnier A., Guillet J., Rabian C., Gluckman E., Saaportes. M. Cord blood T lymphocytes lack constitutive perforin expression in contrast to adult peripheral blood T lymphocytes. Blood. 85:1995;1540-1546.
31. Kataoka T., Shinohara N., Takayama H., Takaru K., Kondo S., Yonehara S., Nagai K. Concanamycin A, powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathway in cell-mediated cytotoxicity. J. Immunol. 156:1996;3678-3686.
32. Lu L., Qian S., Hershberger P. A., Rudert W. A., Lynch D. H., Thomson A. W. Fas ligand (CD95L) and B7 expression on dendritic cells provide counter-regulatory signals for T cell survival and proliferation. J. Immunol. 158:1997;5676-5684.
33. l. Immunity. 3:1995;87-98.
34. Dieu M.-C., Vanbervliet B., Vicari A., Bridon J.-M., Oldham E., Ait-Yahia S., Briere F., Zlotnik A., Lebecque S., Caux C. Selective recruitment of immature and mature dendritic cells by distinct chemokine expressed in different anatomic sites. J. Exp. Med. 188:1998;373-386.
35. Celluzzi C., Mayordomo J. I., Storkus W. J., Lotze M. T., Falo L. D. Peptide-pulsed dendritic cells induce antigen-specific, CTL-mediated protective tumor immunity. J. Exp. Med. 183:1996;283-287.
36. Young J., Inaba K. Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity. J. Exp. Med. 183:1996;7-11.